1-8 of 8
blood-brain barrier disruption
Close
Sort by
Journal Articles

Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predictive Biomarkers and Clinical Outcomes

Noa G. Holtzman, MD, Soren M. Bentzen, PhD DMSc, Vivek Kesari, MD, Ali Bukhari, MD, Firas El Chaer, MD, Elizabeth Hutnick, RN, Kathleen Ruehle, RN, Natalie Gahres, RN, Neil Porter, MD, Carl Shanholtz, MD, Mehmet Hakan Kocoglu, MD, Ashraf Z. Badros, Babak Saboury, MD MPH, Jean A. Yared, MD, Nancy M. Hardy, MD, Aaron P. Rapoport, Saurabh Dahiya, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3239.
https://doi.org/10.1182/blood-2019-125400
Published: 2019
Journal Articles

Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after CD19 CAR-T Cell Immunotherapy

Cameron J. Turtle, MBBS, PhD, Kevin A. Hay, MD FRCPC, MSc, Laila-Aicha Hanafi, PhD, Juliane Gust, MDPhD, W. Conrad Liles, MDPhD, José A. López, MD, Junmei Chen, PhD, Dominic W. Chung, PhD, Mark M Wurfel, MDPhD, Susanna Harju-Baker, PhD, Hasan Ozpolat, MD, Daniel Li, PhD, David Myerson, MDPhD, Luis F. Gonzalez-Cuyar, MD, Cecilia Yeung, MD, Kathleen R. Fink, MD, Stanley R. Riddell, MD, David G. Maloney, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 805.
https://doi.org/10.1182/blood.V130.Suppl_1.805.805
Published: 2017
Journal Articles

Factor XIII Deficiency Improves Motor Function in Mice Challenged with Experimental Autoimmune Encephalomyelitis, An Established Model of Multiple Sclerosis

Eric S. Mullins, MD, Kathryn E. Talmage, Keith W. Kombrinck, Whitney M Miller, Joseph S. Palumbo, MD, Jay L. Degen, PhD
Journal: Blood
Blood (2011) 118 (21): 858.
https://doi.org/10.1182/blood.V118.21.858.858
Published: 2011
Journal Articles

Enhanced Delivery of Rituximab In Combination with Methotrexate-Based Blood-Brain Barrier Disruption for Patients with Newly Diagnosed Primary CNS Lymphoma.

Nancy D. Doolittle, Dale F. Kraemer, Cynthia Lacy, Rose Marie Tyson, Edward A. Neuwelt
Journal: Blood
Blood (2010) 116 (21): 2792.
https://doi.org/10.1182/blood.V116.21.2792.2792
Published: 2010
Journal Articles

Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor

Donghui Zhu, Yaoming Wang, Itender Singh, Robert D. Bell, Rashid Deane, Zhihui Zhong, Abhay Sagare, Ethan A. Winkler, Berislav V. Zlokovic
Journal: Blood
Blood (2010) 115 (23): 4963–4972.
https://doi.org/10.1182/blood-2010-01-262386
Published: 2010
Includes: Supplemental data
Journal Articles

Primary Central Nervous System Lymphoma of T-Cell Phenotype: A Rare Variant of Non-Hodgkin’s Lymphoma Treated with CNS Directed Therapy

Nancy D Doolittle, Ph.D., Edward A Neuwelt, M.D.
Journal: Blood
Blood (2008) 112 (11): 4965.
https://doi.org/10.1182/blood.V112.11.4965.4965
Published: 2008
Journal Articles

Methotrexate and/or Rituximab in a New Nude Rat Central Nervous System Lymphoma Model: Efficacy, Toxicity and Magnetic Resonance Imaging.

Kristoph Jahnke, MD, Leslie L. Muldoon, PhD, Csanad G. Varallyay, MD, Seth J. Lewin, BS, Robert D. Brown, Dale F. Kraemer, PhD, Carole Soussain, MD, Edward A. Neuwelt, MD
Journal: Blood
Blood (2007) 110 (11): 4515.
https://doi.org/10.1182/blood.V110.11.4515.4515
Published: 2007
Journal Articles

Reduction of Prothrombin in Mice Carrying a Conditional Knockout Allele Attenuates the Development of Paralysis Associated with Experimental Encephalitis.

Eric S. Mullins, MD, Keith W. Kombrinck, MS, Matthew J. Flick, PhD, Maureen A. Shaw, BS, William Sun, PhD, Sandra J. Degen, PhD, Katerina Akassoglou, PhD, Jay L. Degen, PhD
Journal: Blood
Blood (2007) 110 (11): 407.
https://doi.org/10.1182/blood.V110.11.407.407
Published: 2007